PRCT compared with MESO: revenue, margins and what each company keeps, and the suppliers and customers both name

PRCTPROCEPT BioRobotics Corp

Mkt capRevenueRevenue

MESOMesoblast Ltd

Mkt capRevenueRevenue

Compare

PRCTPROCEPT BioRobotics Corp

MESOMesoblast Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PRCTPROCEPT BioRobotics Corp

22.60▲+12.05%

Mkt cap$1.2BRevenue$94MQ2 FY26Revenue$308MFY25

MESOMesoblast Ltd

14.28▼−3.32%

Regular sessionNov 4 '26

Mkt cap$3.8BRevenue—Revenue—

Compare

Regular sessionNov 4 '26

PRCTPROCEPT BioRobotics Corp

MESOMesoblast Ltd

22.60▲+12.05%

Price

14.28▼−3.32%

$1.2B

Mkt cap

$3.8B

Q2 FY26$94M

Revenue

—

FY25$308M

Revenue

—

PRCT22.60▲+12.05%vsMESO14.28▼−3.32%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PRCT: latest quarter is a loss; flow not drawable. MESO: latest quarter not drawable.Method ›

Price

rebased to 0%

PRCT, solidMESO, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRCT 2

—HydroCisionunlistedsupplier

—AquaBeamunlistedsupplier

Shared 0

No shared counterparties.

Only MESO 11

TAKTakeda Pharmaceuticalcustomer

—Doculogicsunlistedsupplier

—Lonza Bioscience Singapore Pteunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Lonza Biosciences Singapore Pte

unlistedsupplier

7 more · MESO chain ›